Conjugated hepcidin mimetics
US11753443B2 · kind B2 · utility
2Cited by
47References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2019 |
| Grant date | Sep 12, 2023 |
| Priority date | — |
| Expiry date | Feb 8, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides hepcidin analogues with improved in vivo half lives, and related pharmaceutical compositions and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.